As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …

With the aging of global population, the incidence of nonalcoholic fatty liver disease
(NAFLD) has surged in recent decades. NAFLD is a multifactorial disease that follows a …

The burden of chronic liver disease is globally increasing at an alarming rate. Chronic liver
injury leads to liver inflammation and fibrosis (LF) as critical determinants of long-term …

Liver fibrosis (LF) is a pathological repair reaction caused by a chronic liver injury that affects
the health of millions of people worldwide, progressing to life-threatening cirrhosis and liver …

Activated hepatic stellate cells (HSCs) are considered the key driver of excessive
extracellular matrix and abnormal angiogenesis, which are the main pathological …

Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic
steatohepatitis (NASH) have emerged as the leading causes of chronic liver disease-related …

Cirrhosis is a severe form of liver fibrosis that results in the irreversible replacement of liver
tissue with scar tissue in the liver. Environmental toxicity, infections, metabolic causes, or …

The complex interplay between dietary factors, inflammation, and macrophage polarization
is pivotal in the pathogenesis and progression of chronic liver diseases (CLDs). Omega-3 …

Liver fibrosis is a common pathological process of chronic liver diseases, including viral
hepatitis and alcoholic liver disease, and ultimately progresses to irreversible cirrhosis and …

Abstract Context Schisandrin B (Sch B), an active ingredient from Schisandrae chinensis
(Turcz.) Baill.(Schisandraceae) Fructus, possesses diverse pharmacological activities …